Clinical special tests are a mainstay of orthopaedic diagnosis. Within the context of the evidence-based practice paradigm, data on the diagnostic accuracy of these special tests are frequently used in the decision-making process when determining the diagnosis, prognosis, and selection of appropriate intervention strategies. However, the reported diagnostic utility of these tests is signifi cantly affected by study methodology of diagnostic accuracy studies. Methodological shortcomings can infl uence the outcome of such studies, and this in turn will affect the clinician's interpretation of diagnostic fi ndings. The methodological issues associated with studies investigating the diagnostic utility of clinical tests have mandated the development of the STARD (Standards for Reporting of Diagnostic Accuracy) and QUADAS (Quality Assessment of Diagnostic Accuracy Studies) criterion lists. The purpose of this paper is to outline the STARD and QUADAS criterion lists and to discuss how these methodological quality assessment tools can assist the clinician in ascertaining clinically useful information from a diagnostic accuracy study.
T he clinician's armamentarium for screening, diagnosis, and prognosis of selected conditions has expanded with the creation of numerous clinical special tests. Diagnostic tests are decidedly dynamic, as new tests are developed concurrently with improvements in technology 1 . These clinical tests remain extremely popular among orthopaedic diagnosticians, and information gained from these tests is frequently considered during decision-making with regard to patient diagnosis and prognosis and the selection of appropriate interventions. Historically, textbooks describing these tests have ignored mention of the tests' true ability to identify the presence of a particular disorder as based on studies into diagnostic utility of these tests; rather, they have concentrated solely on test description and scoring. Relying solely on a pathophysiologic and/or pathobiomechanical rationale for the interpretation of clinical tests without considering the research data on diagnostic accuracy of said tests can potentially result in the selection of tests that provide little worthwhile diagnostic or prognostic information. In addition, it can lead clinicians to make incorrect treatment decisions 1 . With the number of clinical special tests and measures continuing to multiply, it is essential to thoroughly evaluate a test's diagnostic utility prior to incorporating it into clinical practice 2, 3 . Clinical special tests exhibit the measurable diagnostic properties of sensitivity and specifi city. The sensitivity of a test is the ability of the test to identify a positive fi nding when the targeted diagnosis is actually present (i.e., true positive) 4 . Specifi city is the discriminatory ability of a test to identify if the disease or condition is absent when in actuality it is truly is absent (i.e., true negative) 4 . Sensitivity and specifi city values can then be used to calculate positive and negative likelihood ratios (LR). Although sensitivity and specifi city-when high-are useful for confi rming the presence or absence of a specifi c disorder, the general consensus seems to be that likelihood ratios are the optimal statistics for determining a shift in the pretest probability that a patient has a specifi c disorder. Table  1 provides information on statistics relevant to diagnostic utility.
Clinical special tests that demonstrate strong sensitivity are considered clinically useful screening tools 5 in that they can be used for ruling out selected diagnoses or impairments 6 . When a test demonstrates high sensitivity, the likelihood of a false negative fi nding (i.e., incorrectly identifying the patient as not having the disorder when in reality she actually does have said condition) is low since the test demonstrates the substantive ability to identify those who truly have the disease or impairment, thus demonstrating the ability to "rule out" a condition. Conversely, tests that demonstrate high specifi city are appropriate for "ruling in" a fi nding, indicating that a positive value is more telling than a negative value. The likelihood of a false positive is low because the test demonstrates the ability to correctly identify those who truly do not have the disease or impairment. This ability of highly sensitive and highly specifi c tests to rule in a condition or rule out a condition, respectively, is captured in the mnemonic below:
• SnNOUT: With highly Sensitive tests, a Negative result will rule a disorder OUT • SpPIN: With highly Specifi c tests, a Positive result will rule a disorder IN Likelihood ratios can be either positive or negative. A positive likelihood ratio (LR+) indicates a shift in probability favoring the existence of a disorder if the test is found to be positive. A value of 1 indicates an equivocal strength of diagnostic power; values that are higher suggest greater strength. Conversely, a negative likelihood ratio (LR-) indicates a shift in probability favoring the absence of a disorder if the test is found to be negative. The lower the value, the better the ability of the test to determine the post-test odds that the disease is actually absent in the event the fi nding is negative. A number closer to 1 indicates that a negative test is equally likely to occur in individuals with or without the disease. Table 2 represents the shifts in probability associated with specifi c range of positive and negative likelihood ratios that a patient does or does not have a particular disorder given a positive or negative test 7 .
With the intent of providing a comprehensive overview of all statistical measures relevant to diagnostic utility, Table  1 also provides defi nitions for three additional statistics. The accuracy of a diagnostic test provides a quantitative measure of its overall value, but because it does not differentiate between the diagnostic value of positive and negative test results, its value with regard to diagnostic decisions is minimal. At fi rst sight, positive and negative predictive values seem to have greater diagnostic value. However, because the prevalence in the clinical population being examined has to be identical to the prevalence in the study population from which the predictive values were derived before we can justifi ably use predictive values as a basis for diagnostic decisions, their usefulness is again limited.
Many orthopaedic clinical tests are products of traditional examination methods and principles; i.e., the tests reported a sensitivity of 100%, exclusively for identifying patients with cervical radiculopathy. Consequently, Spurling's maneuver has been frequently used as a tool for screening for or, in some cases, diagnosing cervical radiculopathy and cervical herniated disks [9] [10] [11] [12] [13] . 14 reported a sensitivity of 30% and a specifi city of 93%. Additional researchers [11] [12] have found sensitivities similar to those reported in these two studies 9, 14 . However, none have reported values near 100%. Since the numbers among studies are dramatically different, clinicians are left with the following question: Is the test more appropriately used as a screening tool as advocated by Spurling and Scoville 8 or as a measure of fair to moderate diagnostic utility as suggested by a number of other authors?
The answer lies in the methodological rigor in the study design and the applicability of these fi ndings to the diagnostic environment of the practicing clinician. Methodological issues can infl uence the outcome of diagnostic utility studies, and this in turn should affect the clinician's interpretation of diagnostic fi ndings. The methodological issues associated with studies investigating the diagnostic utility of clinical tests have mandated the development of criterion lists to systematically determine the methodological quality of diagnostic utility studies, i.e., the STARD (Standards for Reporting of Diagnostic Accuracy) and QUADAS (Quality Assessment of Diagnostic Accuracy Studies) criteria. The purpose of this paper is to outline the STARD and QUADAS criteria and to discuss how these criteria can assist the clinician in ascertaining clinically useful information from a diagnostic accuracy study.
Common Design Errors in Diagnostic Accuracy Studies
A rigorous evaluation process of the true accuracy of clinical special tests can reduce the rate of erroneous diagnostic results 15 . Exaggerated reports of diagnostic utility from poorly designed studies can potentially result in an inaccurate diag- nosis, inappropriate treatment, premature adoption of a special test that provides little value, and errors in clinical decision-making 16 . Past studies have suggested that the methodological qualities of many studies designed to investigate the diagnostic utility of clinical tests are mediocre at best 16 . Numerous methodological shortcomings are apparent in the design of diagnostic accuracy studies. When investigating the accuracy of a special test, the test under investigation is compared to a gold standard or reference test (criterion test) that is considered the best available representation of the truth with regard to the condition of interest (i.e., the reference test is expected to identify all those with the disorder) 17, 18 . In most instances, the optimal reference test consists of fi ndings during surgical intervention. In cases where the reference standard is disputed, controversial, or diffi cult to identify, authors have suggested the use of a clinical diagnosis of similar signs and symptoms, often predicated on the erroneous assumption that the clinical tests selected as a reference standard are explicit to the disorder that is being measured. For example, Cibulka and Koldehoff 19 have suggested the use of a cluster of purported sacroiliac tests to defi ne those who do and do not exhibit symptoms of low back pain. This suggests that the cluster of tests offers clinical utility without the need for the currently most used reference standard for the identification of sacroiliac pathology, i.e., a sacroiliac joint injection. Studies such as these can thereby artifi cially infl ate the identifi ed diagnostic accuracy fi ndings, and studies using this form of a reference standard run the risk of signifi cant bias that can result in inaccurate fi ndings.
Second, many diagnostic utility studies suffer from spectrum or selection bias 4 . Spectrum or selection bias occurs when the subjects of a particular study are not representative of the population to which the test is generally applied. Consider the situation in which the population that is tested in the study consists of those subjects who have a high prevalence of a specifi c condition inferring a high likelihood that the disorder is present. This may occur when studies are performed in specialized secondary centers, such as specifi c pain centers or surgical offi ces. This causes the likelihood that the test will be found positive to exceed that of the population that might be suspected of having the condition studied and that would typically present to primary centers such as physical therapy or chiropractic clinics and primary care 20 provides an example of spectrum bias that infl ated the sensitivity of the test and thereby artifi cially heightened the LR+. Kim et al 20 evaluated the ability of the biceps load test to identify the presence of a labral tear in 75 successive patients with unilateral recurrent anterior shoulder dislocations and a Bankart lesion. The presence of a labral tear in a population of patients with a history of anterior dislocation would be expected to be signifi cantly greater than in a general population presenting with reports of shoulder pain; thus, spectrum bias clearly infl uenced the fi ndings of this study.
Third, numerous studies that have investigated the diagnostic utility of special tests lack appropriate rater blinding. Consequently, clinicians may have a predisposition to select a positive or negative consequence based on knowledge of the results of the reference test fi ndings, other additional diagnostic information, past experience, or personal preference. Glaser et al 21 reported the diagnostic accuracy fi ndings of the Hoffmann's test in diagnosing patients with suspected myelopathy. When blinded to other components of the examination, the authors reported a sensitivity of 28% and a specifi city of 71% (LR+ = 0.96; LR-= 1.01). When the raters were not blinded, the fi ndings increased to a sensitivity of 58% and a specifi city of 74% (LR+= 2.2; LR-= 0.57). Although one may argue that myelopathy requires the understanding of multiple fi ndings-and thus the necessity of not blinding raters-to make a correct diagnosis, this study suggests that the likelihood of reporting a positive fi nding for the Hoffmann's sign was signifi cantly affected by other factors, such as patient history, which lie outside the fi ndings of the individual test. Thus, the diagnostic accuracy of the specifi c test results under investigation may again be artifi cially infl ated.
Fourth, many tests lack an appropriate threshold or cutoff score to signify either a positive or negative fi nding. Altering the cut-off point that determines whether a test is positive or negative can signifi cantly affect the sensitivity and specifi city of a test; for the study results to be applied to the clinical situation, operational defi nitions of positive and negative test fi ndings on dichotomous tests need to be similar.
Finally, in some instances, the results of a special clinical test are inconclusive and do not yield fi ndings that are above or below the threshold and thereby provide only limited clinical usefulness. For example, the straight leg raise (SLR) test is commonly used to determine the presence of lumbar radiculopathy or neural tension [23] [24] [25] . However, the operational defi nition describing whether a test is positive or negative is often disputed [26] [27] , and in some instances what appears as a positive SLR test may not actually signify the presence of lumbar radiculopathy [28] [29] . Subsequently, a fi nding of indeterminate is an appropriate selection in the many Creation and Critique of Studies of Diagnostic Accuracy: Use of the STARD and QUADAS Methodological Quality Assessment Tools / 97 cases where it is diffi cult to identify if a special test is truly either positive or negative. Because the failure to fi nd a positive or negative test can signifi cantly affect the diagnostic usefulness of a test, this consequence should be identifi ed in special clinical tests studies. Therefore, in the development of one of the methodological quality assessment tools discussed below, Bossuyt et al 22 recommended the use of a third category to defi ne tests that are indeterminate, which would provide for a more accurate representation of a test's true diagnostic accuracy.
These examples identify some potential biases associated with establishing the diagnostic utility of clinical special tests. The numerous methodological issues associated with studies investigating the diagnostic utility of clinical tests clearly mandate that specifi c guidelines are necessary to assist with carrying out and critiquing such a study. These methodological issues have resulted in the development of two separate methodological quality assessment tools: the STARD (Standards for Reporting of Diagnostic Accuracy) and the QUA-DAS (Quality Assessment of Diagnostic Accuracy Studies) criterion lists.
Methodological Quality Assessment Tools

STARD Criterion List
In 1999, the Cochrane Diagnostic and Screening Test Methods Working Group met at the Cochrane Colloquium in Rome, Italy 30 . Following the premise set by the CONSORT (Consolidated Standards of Reporting Trials) initiative to develop methodological standards for a specifi c study design, the
Fig. 1. Flow Chart for the STARD (Standards for Reporting Diagnostic Accuracy) checklist.
group developed a checklist of items by way of expert consensus with the focus on improving the design of studies investigating the diagnostic accuracy of tests or measures. The workgroup developed the Standards for Reporting of Diagnostic Accuracy (STARD) checklist, a 25-item checklist created by narrowing the results from an extensive search of the literature that revealed the presence of 33 methodological scoring lists for studies on diagnostic accuracy with 75 distinct individual items 31, 32 . Similar to the CONSORT standards, the STARD checklist is designed to provide researchers with a checklist and fl ow diagram (Figure 1 ) that should be followed for optimal study design. The fl ow diagram outlines a method for patient recruitment, the order of test execution, the number of patients undergoing the index test, and the specifi c reference test selected. Each fl ow phase includes a section for an inconclusive test fi nding (neither positive nor negative) in the index or reference test and provides a venue by which this can be identifi ed.
The STARD checklist is divided into fi ve major topics and six subsequent subtopics. The fi ve major topics-1) title, abstract, and keywords; 2) introduction; 3) methods; 4) results; and 5) discussion-provide suggestions for study design and reporting of the results to improve the reader's ability to identify and judge the methodological rigor of diagnostic accuracy studies. Each of the six subsequent subtopics further break down the elemental design for participants, test methods and application, statistical methods, and estimates of diagnostic accuracy. By using the checklist during the design phase, researchers are less apt to incorporate fatal study errors such as recruitment or selection bias or overlap between the index test and reference test fi ndings, and readers are more likely to improve their critique of diagnostic accuracy study secondary to standardization of reporting and design. Table 4 outlines the STARD checklist.
QUADAS Criterion List
Recently, the Quality Assessment of Diagnostic Accuracy Studies (QUADAS) tool was developed to assess the quality (both internal and external) of primary research studies of diagnostic accuracy 33 . QUADAS was developed through a fourround Delphi panel, which reduced 28 critical criteria for evaluation of a completed diagnostic accuracy study to 14 fi nal components. Within the 14 components outlined in Table 5 , three overall criteria that are assessed include 1) reporting of selection criteria, 2) description of index test execution, and 3) description of reference standard execution. Each of the 14 steps is scored as "yes," "no," or "unclear." Whiting et al 3 provided individual procedures for scoring each of the 14 items, including operational standards for each question. In research terms, the QUADAS tool provides an organized format in which readers can examine the internal validity and external validity of a study.
Current Research Status of STARD and QUADAS Tools
Nonetheless, at present, neither QUADAS nor STARD is used in quantifying a value or score for diagnostic accuracy 34 . At best, systematic reviews that use the QUADAS instrument provide a qualitative assessment of design with recognition that weaknesses in selected regions may alter some test fi ndings more than others. However, recent interrater reliability testing of the QUADAS has demonstrated adequate agreement for individual items in the checklist (range 50-100%, median 90%) 3 .
Intent of the STARD and QUADAS Tools
The QUADAS and STARD differ from each other in the intent of the instrument. While STARD is a prospective tool used to outline the development of a well-designed study, QUADAS is considered a retrospective instrument used to critique the methodological rigor of a study investigating the diagnostic accuracy of a test or measure. QUADAS is designed to serve as a critique of a completed study and a measure of the study design, and it incorporates many of the same items provided in the checklist by the STARD initiative. The principal purpose of the STARD is to improve the quality of reporting of diagnostic studies. STARD is designed to outline the specifi c features required for an unbiased diagnostic accuracy study and to improve the ability of the reader to gauge the strength of a fi nding through commonality in reporting.
Clinical Application
Despite the difference in intent of the tools, both STARD and QUADAS can be useful for clinicians when determining the strength of a study and hence the value of a selected clinical test. For example, because tests of high sensitivity are useful in ruling out the presence of a condition, incorporating these tests early in the examination is helpful in organizing a thoughtful progression of the remainder of the examination. However, artifi cially low or high sensitivity scores reported by studies with less than optimal scientifi c rigor may bias the clinician's fi ndings potentially resulting in an inaccurate diagnosis. The various reported accuracies of the Spurling's test are examples of potentially misleading fi ndings in that some studies have found the test to be highly sensitive but not specifi c while others have found exactly the opposite. When reviewed using the QUADAS criteria, the studies 8, 10, 13 that found Spurling's test to be sensitive had specifi c components of the QUADAS criteria missing or fi ndings that could increase the risk of selection bias, while those that found the test specifi c 11,12 exhibited fewer missing criteria and greater integrity in selection and interpretation standards (Table 6 ). This suggests that the studies that found higher levels of specifi city were of greater quality and exhibited fi ndings more applicable to clinical practice. Subsequently, it appears that the Spurling's test is not a sensitive test and should not be used as a screening tool. Based on a systematic assessment of the methodological quality of the studies into the diagnostic utility of the Spurling's test, other tests need to be considered to more effectively "rule out" cervical radiculopathy. Of course, within clinical practice, single tests are seldom used as the sole determinant for establishing a diagnosis. Rather, recent orthopaedic research has emphasized the use of test clusters to establish a diagnosis 11 and-with the increasing emphasis on the development of clinical prediction rules within orthopaedic manual physical therapy [34] [35] [36] [37] [38] -an appropriate course of management. These diagnostic test clusters and clinical prediction rule studies can and should, of course, also be assessed for methodological quality using these same assessment tools (STARD and QUA-DAS) with similar implications for their use in clinical practice.
Conclusion
The STARD and the QUADAS tools were developed to improve the construction and reporting (STARD) and the assessment (QUADAS) of diagnostic accuracy studies. Improvement in the study design and reporting of diagnostic accuracy studies should positively infl uence the quality of data available to the clinician on the diagnostic utility of tests used for screening, diagnosis, prognosis, and treatment planning. Clinicians can improve their research-based confi dence in their interpretation of fi ndings on clinical tests and measures by recognizing common biases in diagnostic accuracy studies as discussed above and by familiarizing themselves with and applying the STARD and QUADAS tools to said studies. ■ 
